This inventor holds 1 USPTO granted patent and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Vida Pharma Limited. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Graeme Horne: Innovator in Energy Utilization Disease Treatment
Introduction
Graeme Horne is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of medical science, particularly in the treatment of energy utilization diseases. His innovative work has led to the development of a patent that addresses critical health issues related to metabolic syndrome.
Latest Patents
Horne holds a patent for the "Treatment of energy utilization disease." This patent describes compositions comprising imino sugar acids for the treatment of various conditions associated with metabolic syndrome. These conditions include central obesity, elevated levels of triglycerides, and diabetes, encompassing both type 1 and type 2 diabetes, as well as insulin resistance. The patent also outlines processes for producing these compositions from various plant sources, along with their medical uses and methods.
Career Highlights
Throughout his career, Graeme Horne has worked with several companies, including Vida Pharma Limited and Summit Corporation Plc. His experience in these organizations has contributed to his expertise in developing innovative treatments for complex health issues.
Collaborations
Horne has collaborated with notable individuals in his field, including Robert James Nash and Francis Xavier Wilson. These partnerships have likely enhanced his research and development efforts, leading to advancements in his patented treatments.
Conclusion
Graeme Horne's work in the treatment of energy utilization diseases showcases his dedication to improving health outcomes through innovation. His patent and collaborations reflect his commitment to advancing medical science and addressing significant health challenges.